A detailed history of Grove Bank & Trust transactions in Dexcom Inc stock. As of the latest transaction made, Grove Bank & Trust holds 56 shares of DXCM stock, worth $4,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56
Previous 56 -0.0%
Holding current value
$4,511
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$114.22 - $140.1 $5,596 - $6,864
-49 Reduced 46.67%
56 $7,000
Q3 2023

Oct 30, 2023

BUY
$86.06 - $137.93 $4,216 - $6,758
49 Added 87.5%
105 $9,000
Q2 2023

Jul 27, 2023

SELL
$112.47 - $130.98 $2,474 - $2,881
-22 Reduced 28.21%
56 $7,000
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $7,072 - $8,358
68 Added 680.0%
78 $9,000
Q4 2022

Feb 03, 2023

BUY
$84.98 - $122.67 $849 - $1,226
10 New
10 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.